Dr Frederick Goldberg

Frederick Goldberg is a medicinal chemist in the oncology department at AstraZeneca. He received his masters from Cambridge University in 2000 and PhD at Imperial College London in 2004, then performed postdoctoral studies on a Fulbright scholarship with Philip Magnus at the University of Texas at Austin before returning to the UK in 2006 to work for AstraZeneca. He has worked across all discovery phases in diabetes and oncology disease areas, and his research interests include kinases, structure based design, compound collection enhancement, chemical biology and metabolism. In 2013 he was awarded the EFMC Prize for a Young Medicinal Chemist in Industry.